Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing

被引:71
作者
Passerini, N
Perissutti, B
Albertini, B
Voinovich, D
Moneghini, M
Rodriguez, L
机构
[1] Univ Bologna, Dept Pharmaceut Sci, I-40127 Bologna, Italy
[2] Univ Trieste, Dept Pharmaceut Sci, I-34127 Trieste, Italy
关键词
verapamil HCl; waxy microparticles; controlled release; ultrasonic atomizer; spray congealing;
D O I
10.1016/S0168-3659(03)00009-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this work, the potential of waxes for preparing with the ultrasonic spray congealing technique microparticles for controlling the in vitro release of verapamil HCl was investigated. The first part of the study encompassed the optimisation of the formulation to achieve an efficient drug incorporation together with a satisfactory in vitro drug release rate. In particular, microcrystalline wax, stearyl alcohol and mixtures of the two were used. Also a surfactant (soya lecithin) was added to the formulations. After the particle size analysis, the characterisation of the microparticles involved the study of the solid state of drug and carriers in the systems (DSC, HSM and XRD) and the morphological and chemical analyses of the microparticle surface (SEM and XPS). Finally, the drug release mechanism from these devices was evaluated using the statistical moment analysis. The results of this study show that by selecting the type and the amount of the carriers, microparticles with a spherical shape and a good encapsulation efficiency were observed. These particles showed a zero-order release for 8 h, without modifying the solid state properties of the drug. Therefore, waxy microparticles prepared by the ultrasonic spray congealing technique are promising solvent-free devices for controlling the release of verapamil HCl. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:263 / 275
页数:13
相关论文
共 18 条
[1]   DEVELOPMENT AND EVALUATION OF SUSTAINED-RELEASE IBUPROFEN-WAX MICROSPHERES .1. EFFECT OF FORMULATION VARIABLES ON PHYSICAL CHARACTERISTICS [J].
ADEYEYE, CM ;
PRICE, JC .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1377-1383
[2]  
BHARATHAN G, 1995, MONOCOTYLEDONS SYSTE, V1, P81
[3]  
BODMEIER R, 1997, ENCY PHARM TECHNOLOG, V16, P335
[4]  
BROCKMEIER D, 1982, ARZNEIMITTEL-FORSCH, V32-1, P248
[5]   CHARACTERIZATION OF DRUG LOADING IN CROSPOVIDONE BY X-RAY PHOTOELECTRON-SPECTROSCOPY [J].
CARLI, F ;
GARBASSI, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (09) :963-967
[6]  
Chang ZL, 1988, ANAL PROFILES DRUG S, V17, P643
[7]   Matrix mini-tablets based on starch/microcrystalline wax mixtures [J].
De Brabander, C ;
Vervaet, C ;
Fiermans, L ;
Remon, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (02) :195-203
[8]   Characterization of carbamazepine-gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds [J].
Passerini, N ;
Perissutti, B ;
Moneghini, M ;
Voinovich, D ;
Albertini, B ;
Cavallari, C ;
Rodriguez, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (03) :699-707
[9]  
Pinto JF, 1997, CHEM PHARM BULL, V45, P171
[10]   Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes [J].
Rodriguez, L ;
Passerini, N ;
Cavallari, C ;
Cini, M ;
Sancin, P ;
Fini, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 183 (02) :133-143